Mexican health authorities have approved the first vaccine to gain official acceptance for use against the dengue virus, which infects about 100 million people every year, mostly in Asia, Africa and Latin America.

Mexico’s federal medical safety agency said Wednesday the vaccine has undergone testing on over 40,000 patients worldwide. It said Wednesday the vaccine’s manufacturer had proved its safety and effectiveness, but did not name the drug.

In a separate statement, the Lyon, France-based Sanofi Pasteur identified the vaccine as Dengvaxia.

Read more

Related Articles